{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:51:43Z","timestamp":1784224303585,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clnesp.2025.102896","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:11:53Z","timestamp":1768061513000},"page":"102896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fibre manipulation to manage symptom severity and quality of life in patients with functional bowel disorders: A systematic review"],"prefix":"10.1016","volume":"72","author":[{"given":"Rojina","family":"Raked","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Utter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1453-4447","authenticated-orcid":false,"given":"Kate","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clnesp.2025.102896_bib1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jgh3.12528","article-title":"Gut microbiota dysbiosis in functional gastrointestinal disorders: underpinning the symptoms and pathophysiology","volume":"5","author":"Wei","year":"2021","journal-title":"JGH Open"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7861\/clinmed.2020-0980","article-title":"Management of functional gastrointestinal disorders","volume":"21","author":"Fikree","year":"2021","journal-title":"Clin Med"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.clnesp.2025.102896_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-018-0034-5","article-title":"New treatments and therapeutic targets for IBS and other functional bowel disorders","volume":"15","author":"Simr\u00e9n","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clnesp.2025.102896_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ajg.2013.105","article-title":"Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life","volume":"108","author":"Bohn","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.102896_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.14309\/ajg.0000000000001767","article-title":". The role of food in the treatment of bowel disorders: focus on irritable bowel syndrome and functional constipation","volume":"117","author":"Singh","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.102896_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13197-011-0365-5","article-title":"Dietary fibre in foods: a review","volume":"49","author":"Dhingra","year":"2012","journal-title":"J Food Sci Technol"},{"key":"10.1016\/j.clnesp.2025.102896_bib8","series-title":"Encyclopedia of food chemistry","first-page":"256","article-title":"Starch","author":"Joye","year":"2019"},{"issue":"10","key":"10.1016\/j.clnesp.2025.102896_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103209","article-title":"The health benefits of dietary fibre","volume":"12","author":"Barber","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.102896_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American college of gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Off J Am Coll Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.102896_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.21101\/cejph.a5313","article-title":"Dietary fibre as prebiotics in nutrition","volume":"27","author":"Hijov\u00e1","year":"2019","journal-title":"Cent Eur J Publ Health"},{"issue":"2","key":"10.1016\/j.clnesp.2025.102896_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41575-020-00375-4","article-title":"Dietary fibre in gastrointestinal health and disease","volume":"18","author":"Gill","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7 Suppl","key":"10.1016\/j.clnesp.2025.102896_bib13","doi-asserted-by":"crossref","first-page":"1451s","DOI":"10.1093\/jn\/129.7.1451S","article-title":"Controlled trial of oligofructose in the management of irritable bowel syndrome","volume":"129","author":"Hunter","year":"1999","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.102896_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","article-title":"Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome","volume":"29","author":"Silk","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clnesp.2025.102896_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1017\/S000711450779894X","article-title":"The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders","volume":"99","author":"Paineau","year":"2008","journal-title":"Br J Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.102896_bib16","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ajcn\/72.6.1570","article-title":"Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome","volume":"72","author":"Olesen","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2025.102896_bib17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American college of gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2025.102896_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.clnesp.2025.102896_bib19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ajg.2014.195","article-title":"The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis","volume":"109","author":"Moayyedi","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.clnesp.2025.102896_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/apt.13167","article-title":"Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome","volume":"41","author":"Rao","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.clnesp.2025.102896_bib21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/MEG.0000000000000425","article-title":"The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"27","author":"Nagarajan","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.102896_bib22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ajcn\/nqy376","article-title":"Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"109","author":"Wilson","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.102896_bib23","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.clnesp.2025.102896_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5195\/jmla.2020.834","article-title":"Improving the translation of search strategies using the polyglot search translator: a randomized controlled trial","volume":"108","author":"Clark","year":"2020","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.clnesp.2025.102896_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jclinepi.2020.01.008","article-title":"A full systematic review was completed in 2 weeks using automation tools: a case study","volume":"121","author":"Clark","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.clnesp.2025.102896_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1055\/s-0033-1335260","article-title":"Validation of the IBS-SSS","volume":"51","author":"Betz","year":"2013","journal-title":"Z Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.102896_bib27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/SGA.0b013e3182945881","article-title":"Further validation of the visual analogue scale for irritable bowel syndrome after use in clinical practice","volume":"36","author":"Bengtsson","year":"2013","journal-title":"Gastroenterol Nurs"},{"issue":"7","key":"10.1016\/j.clnesp.2025.102896_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/apt.13746","article-title":"Validity and reliability of the Bristol stool form scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome","volume":"44","author":"Blake","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2025.102896_bib29","first-page":"366","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clnesp.2025.102896_bib31","first-page":"216","article-title":"Cochrane consumers and communication review group: data synthesis and analysis","author":"Ryan","year":"2013","journal-title":"Cochrane Consum Commun Rev Group"},{"issue":"16","key":"10.1016\/j.clnesp.2025.102896_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nu15163526","article-title":"The effects of agave Fructans in a functional food consumed by patients with irritable bowel syndrome with constipation: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Camacho-D\u00edaz","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib33","doi-asserted-by":"crossref","first-page":"2197837","DOI":"10.1080\/19490976.2023.2197837","article-title":"Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial","volume":"15","author":"Lai","year":"2023","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.clnesp.2025.102896_bib34","article-title":"Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial","volume":"33","author":"Remes-Troche","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"issue":"9","key":"10.1016\/j.clnesp.2025.102896_bib35","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.cgh.2021.12.016","article-title":"Supplementing dietary fibers with a low FODMAP diet in irritable bowel syndrome: a randomized controlled crossover trial","volume":"20","author":"So","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2025.102896_bib36","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1017\/jns.2022.9","article-title":"Evaluating tolerability of resistant starch 2, alone and in combination with minimally fermented fibre for patients with irritable bowel syndrome: a pilot randomised controlled cross-over trial","volume":"11","author":"So","year":"2022","journal-title":"J Nutr Sci"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15430\/JCP.2015.20.1.64","article-title":"A controlled, randomized, double-blind trial to evaluate the effect of vegetables and whole grain powder that is rich in dietary fibers on bowel functions and defecation in constipated young adults","volume":"20","author":"Woo","year":"2015","journal-title":"J Cancer Prev"},{"issue":"3","key":"10.1016\/j.clnesp.2025.102896_bib38","first-page":"267","article-title":"Efficacy of pectin in the treatment of diarrhea predominant irritable bowel syndrome","volume":"18","author":"Xu","year":"2015","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"5","key":"10.1016\/j.clnesp.2025.102896_bib39","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00394-024-03398-8","article-title":"Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial","volume":"63","author":"JanssenDuijghuijsen","year":"2024","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnesp.2025.102896_bib40","doi-asserted-by":"crossref","first-page":"goae101","DOI":"10.1093\/gastro\/goae101","article-title":"Supplementation with probiotics, prebiotics, and synbiotics in patients with chronic functional constipation: a randomized, double-blind, placebo-controlled pilot clinical trial","volume":"12","author":"Terr\u00e9n Lora","year":"2024","journal-title":"Gastroenterol Rep"},{"issue":"5","key":"10.1016\/j.clnesp.2025.102896_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MCG.0000000000001888","article-title":"Agave tequilana fructans versus psyllium plantago for functional constipation: randomized double-blind clinical trial","volume":"58","author":"Coss-Adame","year":"2024","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.102896_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1008841022998","article-title":"Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease","volume":"7","author":"Revicki","year":"1998","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Off J Am Coll Gastroenterol"},{"issue":"8","key":"10.1016\/j.clnesp.2025.102896_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib46","article-title":"A systematic review and meta-analysis of diet and nutrient intake in adults with irritable bowel syndrome","volume":"36","author":"Veraza","year":"2024","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.clnesp.2025.102896_bib47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijbiomac.2020.12.175","article-title":"Cellulosic and hemicellulosic fractions of sugarcane bagasse: potential, challenges and future perspective","volume":"169","author":"Kumar","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.clnesp.2025.102896_bib48","doi-asserted-by":"crossref","first-page":"808195","DOI":"10.3389\/fphar.2022.808195","article-title":"Current treatment options and therapeutic insights for gastrointestinal dysmotility and functional gastrointestinal disorders","volume":"13","author":"Singh","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102896_bib49","article-title":"Roles of gut microbiota and metabolites in pathogenesis of functional constipation","volume":"2021","author":"Wang","year":"2021","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725032097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725032097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:51:43Z","timestamp":1774057903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725032097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"alternative-id":["S2405457725032097"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.102896","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibre manipulation to manage symptom severity and quality of life in patients with functional bowel disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.102896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}],"article-number":"102896"}}